Business Description
EV Biologics Inc
NAICS : 541714
SIC : 2834
ISIN : KYG988472083
Description
EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.69 | |||||
| 9-Day RSI | 39.52 | |||||
| 14-Day RSI | 41.91 | |||||
| 6-1 Month Momentum % | -56.8 | |||||
| 12-1 Month Momentum % | -78.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -13.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 0.01 | |||||
| EV-to-EBIT | -1.49 | |||||
| EV-to-EBITDA | -1.49 | |||||
| EV-to-Revenue | 0.06 | |||||
| Earnings Yield (Greenblatt) % | -67.11 | |||||
| FCF Yield % | -252.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:YECO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EV Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 38.723 | ||
| EPS (TTM) ($) | -3.55 | ||
| Beta | 0 | ||
| Volatility % | 69.65 | ||
| 14-Day RSI | 41.91 | ||
| 14-Day ATR ($) | 0.010627 | ||
| 20-Day SMA ($) | 0.236708 | ||
| 12-1 Month Momentum % | -78.2 | ||
| 52-Week Range ($) | 0.2031 - 1 | ||
| Shares Outstanding (Mil) | 10.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EV Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EV Biologics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
EV Biologics Inc Frequently Asked Questions
What is EV Biologics Inc(YECO)'s stock price today?
The current price of YECO is $0.21. The 52 week high of YECO is $1.00 and 52 week low is $0.20.
When is next earnings date of EV Biologics Inc(YECO)?
The next earnings date of EV Biologics Inc(YECO) is .
Does EV Biologics Inc(YECO) pay dividends? If so, how much?
EV Biologics Inc(YECO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers